Navigation Links
Anastrozole Confirmed Superior in Breast Cancer Prevention
Date:12/14/2007

SAN ANTONIO, Dec. 14 /PRNewswire/ -- Anastrozole is more effective than tamoxifen at preventing breast cancer recurrence for periods of at least 10 years in women with hormone-responsive cancers. In addition, the increased risk of fractures that has been seen in some patients being treated with anastrozole disappears after treatment ends.

Speaking at the Thursday session of the San Antonio Breast Cancer Symposium, Professor John Forbes of the University of Newcastle presented the much-anticipated long-term results of the ATAC (Anastrozole, Tamoxifen, Alone or in Combination) trial that compared 5 years of tamoxifen with 5 years of the aromatase inhibitor anastrozole for the treatment of postmenopausal women with invasive breast cancer.

Hormone-responsive breast cancers require estrogen stimulation in order to grow. Tamoxifen, a synthetic variation of estrogen, binds to hormone receptors on hormone-sensitive cancer cells, preventing estrogen from attaching to the cells. Anastrozole, on the other hand, prevents the manufacture of estrogen by body tissues other than the ovaries (e.g., fat cells), so it is useful for the treatment of hormone-sensitive cancers in postmenopausal women whose ovaries are no longer producing estrogen.

Although previous reports at 33 and 68 months demonstrated that anastrozole was more effective, has fewer serious side effects, and was better tolerated than tamoxifen during the period of treatment, it was not known whether the benefits or side effects associated with anastrozole would persist long term after patients were no longer taking the drug.

After 10 years (5 years after the completion of treatment), patients who had taken anastrozole continued to show reduced rates of tumor recurrence and metastasis compared with patients who had taken tamoxifen. In fact, the relative benefit of anastrozole actually increased compared with results seen immediately after the completion of treatment.

Most striki
'/>"/>

SOURCE San Antonio Breast Cancer Symposium
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Game Commission Announces EHD Confirmed in Fayette County
2. Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria
3. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
4. Edwards Resilient Trial Demonstrates Statistically Superior Results for Treating Peripheral Arterial Disease in the Leg
5. IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
8. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
9. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
10. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
11. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... , Sept. 22, 2014 The western ... stage. It is largely a replacement market with ... The mergers, acquisitions and partnerships are redefining competitive ... This research service provides details about revenue forecasts, ... pricing trends across the country. The changing landscape ...
(Date:9/22/2014)... A study on the global ... to Transparency Market Research,s database of market reports. Titled ... Share & Forecast (2011 - 2017)", the report indicates ... billion in 2011, would observe growth at a CAGR ... the report), and end-up valuing US$ 4.8 billion by ...
(Date:9/22/2014)... SHANGHAI , Sept. 22, 2014  Continua ... leader in healthcare technology, media and telecommunications,  have ... in China and promote ... and BHG announced this new partnership during the ... in Washington, DC , while ...
Breaking Medicine Technology:Automated Endoscope Reprocessor Market Trends in Western Europe 2Automated Endoscope Reprocessor Market Trends in Western Europe 3Global Magnetic Resonance Imaging (MRI) Market Worth US $4.8 Billion by 2017: Transparency Market Research 2Global Magnetic Resonance Imaging (MRI) Market Worth US $4.8 Billion by 2017: Transparency Market Research 3Global Magnetic Resonance Imaging (MRI) Market Worth US $4.8 Billion by 2017: Transparency Market Research 4Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 2Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 4
... N.J., Oct. 10, 2011 The New Jersey Patient Care ... the Garden State, encourages men and their families to speak ... Preventive Services Task Force (USPSTF) recommended healthy men should no ... routine cancer screening. This decision was made ...
... 10, 2011 IRIDEX Corporation (Nasdaq: IRIX ) ... President and Chief Executive Officer effective today. Dr. Beck replaces ... Chief Technology Officer, and will also replace Mr. Boutacoff on ... has spent the majority of his career in leadership and ...
Cached Medicine Technology:NJ Docs Say Cancer Detection Tool Saves Lives 2IRIDEX Names Veteran Healthcare Executive Dominik Beck President, CEO 2IRIDEX Names Veteran Healthcare Executive Dominik Beck President, CEO 3IRIDEX Names Veteran Healthcare Executive Dominik Beck President, CEO 4
(Date:9/22/2014)... Sept. 22, 2014 (HealthDay News) -- All sexually ... the most common sexually transmitted infections: chlamydia and ... Preventive Services Task Force. The task ... younger than 24 years of age and pregnant ... don,t develop noticeable symptoms. As a result, many ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 Transvaginal ... Scientific Corp. continue to move forward in the ... Court, Southern District of West Virginia, Bernstein Liebhard ... Docket Control Order was issued by the Court ... matters pertaining to the upcoming trial for consolidated ...
(Date:9/22/2014)... HealthDay Reporter MONDAY, Sept. 22, ... newborn intensive care units (NICU) set up private rooms for ... finds. Researchers at one children,s hospital found that preemies ... when their NICU switched from the traditional "open-bay" layout to ... 22 in the journal Pediatrics , add to evidence ...
(Date:9/22/2014)... Alan Mozes HealthDay ... Pediatricians, take note: Many American parents are aware of online ... choose a pediatrician for their children, according to a new ... more than 1,600 parents -- further suggest that negative online ... that doctor has been recommended by a neighbor. Conversely, ...
(Date:9/22/2014)... transplant seems futuristic, if not impossible. But with ... Defense, researchers at University of California, San Diego ... of an entire, functional eye a reality. , ... grail for vision restoration," said Jeffrey Goldberg, MD, ... colleagues at University of Pittsburg Medical Center and ...
Breaking Medicine News(10 mins):Health News:Screen Women for Chlamydia, Gonorrhea, Experts Say 2Health News:Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Boston Scientific Litigation, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Boston Scientific Litigation, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Boston Scientific Litigation, Bernstein Liebhard LLP Reports 4Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 2Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 3Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 2Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 3Health News:Looking ahead: Whole eye transplant under development 2
... unexpectedly wetter than earlier believed, a new study carried ... said. ,According to the satellite-based research ... have risen, but precipitation has also kept pace. ... of climate models to accurately predict precipitation on regional ...
... in Hong Kong have identified a protein in human sperm ... infertility . ,As part of the study, researchers examined ... They found that the sperms of mutant mice had very ... ,'(The protein) is involved in the transport of bicarbonate, ...
... show highlighting the need for more organ donors, or a ... of controversy, a Dutch channel Friday was to air a ... ,The controversy stirred by "The Big DonorShow" has ... broadcaster BNN is determined to go ahead. ,While ...
... dollars spent on national security in airports, a man infected ... travel unhindered into the United States, underscoring how drug-resistant strains ... against the U.S. ,The attention this story has been ... it's just a glimpse of the potential nightmare ahead. ...
... who spent 19 years in a coma has woken up and will ... longer in power, a television station announced Friday. ,Railwayman ... train in 1988, the private channel Polsat said. In an interview, Grzebski ... ,"She's the one who always took care of me. She saved my ...
... court procedure and family disputes regarding the latest woman in ... health , say his close friends and well-wishers. ... a close friend told IANS. ,The actor is ... state of acute pain. ,'Two of the bones ...
Cached Medicine News:Health News:World may Get Much Wetter With Global Warming Than Believed 2Health News:Shock TV Reality Organ Donor Show Goes on Air 2Health News:Shock TV Reality Organ Donor Show Goes on Air 3Health News:New Strains of TB Can Be Used as a Powerful Bioterror Weapon 2Health News:New Strains of TB Can Be Used as a Powerful Bioterror Weapon 3Health News:Stress-Related Health Problems Haunts Sanjay Dutt 2
... A particular challenge in transseptal left heart ... must be exchanged for a sheath with ... wall position. Traditionally, such an exchange has ... heparinized patient. Biosense Webster has overcome this ...
Coaxial Multicolor LIO Worlds first coaxial multicolor LIO provides precise laser delivery with repeatable outcomes, as well as maximum treatment options and physician safety....
... Trio The pinnacle in ... diode-pumped solid-state (DPSS) 532 Photocoagulator ... (SLT) and offering maximum flexibility ... first and only Nd:YAG, Photocoagulator ...
... Delivery System is an advanced guiding ... of permanent leads during CRT implantation ... System is made from PEBAX and ... plus high radial strength to resist ...
Medicine Products: